Moffitt Cancer Centers National Cancer Institute Designation Renewed pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.
PITTSTON — Paint Pittston Pink (PPP) recently received a $1,000 donation from the Luzerne County Bar Association Charitable Foundation Inc. at Fox Hill Country…
Moffitt Physician receives NCI Cancer Clinical Investigator Team Leadership Award eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Dr. Maulik Majmuda has joined Boston-based virtual care and digital therapeutics company
Biofourmis as its chief medical officer, the company announced this week.
Prior to this new role, Majmudar served as medical office at Amazon, where he led the development and launch of Amazon Halo. He also completed a stint at Massachusetts General Hospital as an associate director of the Healthcare Transformation Lab, and was an assistant professor at Harvard Medical School.
Majmudar has a history with Biofourmis. He joined the company’s clinical advisory board in 2015 and has served on its board of directors since 2019.
As CMO, he will work to expand the company’s clinical care services, oversee product management, data science and clinical affairs.
Credit: Moffitt Cancer Center
TAMPA, Fla. Tumors are genetically diverse with different mutations arising at different times throughout growth and development. Many models have tried to explain how genetic heterogeneity arises and what impact these alterations have on tumor growth. In a new article published in
Nature Communications, Moffitt Cancer Center researchers show how the location of the tumor and spatial constraints put on it by the surrounding tissue architecture impact genetic heterogeneity of tumors.
Genetic differences are apparent among tumors from different patients, as well as within different regions of the same tumor of an individual patient. Some of these mutations may benefit the tumor and become selected for, such as mutations that allow the tumor to grow faster and spread to other sites. This type of tumor evolution is known as Darwinian evolution. Alternatively, other cellular mutations may have no immediate impact on the tumor but still accumulate over